Related Experiment Videos

Predictors of severe chest infections in pediatric neuromuscular disorders

C Dohna-Schwake1, R Ragette, H Teschler

  • 1Department of Pediatrics and Pediatric Neurology, University hospital of Essen, Hufelandstr. 55, 45122 Essen, Germany. christian.schwake@uni-essen.de

Neuromuscular Disorders : NMD
|April 20, 2006
PubMed

Insights

Lung and respiratory muscle function, including peak cough flow, can predict chest infections in children with neuromuscular disorders. Low Inspiratory Vital Capacity (IVC) and peak cough flow (PCF) identify high-risk patients needing monitoring and assisted coughing.

Area of Science:

  • Pediatric Pulmonology
  • Neuromuscular Disorders
  • Respiratory Medicine

Background:

  • Chest infections are a significant concern for individuals with neuromuscular disorders.
  • Predictive value of respiratory function tests for chest infections in this population is not well-established.

Purpose of the Study:

  • To evaluate the predictive value of lung and respiratory muscle function tests, including peak cough flow, for severe chest infections in pediatric patients with neuromuscular disorders.

Main Methods:

  • Retrospective analysis of 46 children and adolescents with neuromuscular disorders.
  • Assessed lung function (Inspiratory Vital Capacity - IVC), respiratory muscle function (Peak Expiratory Pressure - PEP), and peak cough flow (PCF).
  • Correlated these measures with the number of chest infections, antibiotic treatment days, and history of hospitalization for severe chest infection.

Main Results:

  • Number of chest infections and antibiotic days correlated with IVC, PCF, and PEP.
  • Patients hospitalized for severe chest infections had significantly lower IVC (0.65 vs. 1.44 L) and PCF (116 vs. 211 L/min) compared to non-hospitalized patients.
  • IVC < 1.1 L and PCF < 160 L/min were identified as sensitive and specific thresholds for predicting severe chest infections.

Conclusions:

  • Spirometry (IVC) and peak cough flow (PCF) are reliable indicators for identifying pediatric patients with neuromuscular disorders at high risk of severe chest infections.
  • Patients with IVC < 1.1 L and/or PCF < 160 L/min require close monitoring and consideration for assisted coughing techniques.

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Assessment of Airway, Skin Color, and Use of Accessory Muscles01:30

Assessment of Airway, Skin Color, and Use of Accessory Muscles

A thorough assessment of respiratory health is paramount in clinical settings to identify and manage respiratory distress and ensure adequate oxygenation. This article elaborates on the critical aspects of respiratory evaluation, including airway assessment, skin color examination, and the observation of accessory muscle use, which are integral to effectively diagnosing and managing patients with respiratory conditions.
Introduction
The initial evaluation of a patient's respiratory system...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: